AUTHOR=McEntire Caleb R. S. , Song Kun-Wei , McInnis Robert P. , Rhee John Y. , Young Michael , Williams Erika , Wibecan Leah L. , Nolan Neal , Nagy Amanda M. , Gluckstein Jeffrey , Mukerji Shibani S. , Mateen Farrah J. TITLE=Neurologic Manifestations of the World Health Organization's List of Pandemic and Epidemic Diseases JOURNAL=Frontiers in Neurology VOLUME=Volume 12 - 2021 YEAR=2021 URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.634827 DOI=10.3389/fneur.2021.634827 ISSN=1664-2295 ABSTRACT=The World Health Organization (WHO) monitors the spread of diseases globally and maintains a list of twenty diseases with epidemic or pandemic potential: Chikungunya, cholera, Crimean-Congo hemorrhagic fever, ebola virus disease, Hendra virus infection, influenza, Lassa fever, Marburg virus disease, Neisseria meningitis, MERS-CoV, monkeypox, Nipah virus infection, novel coronavirus (2019-nCoV), plague, Rift Valley fever, SARS, smallpox, tularemia, yellow fever, and Zika virus disease. These pathogens are increasingly important on the global stage. The majority of these diseases have neurological manifestations. Those with less frequent neurological manifestations may also have important consequences. This is highlighted now in particular through the ongoing COVID-19 pandemic, and reinforces that pathogens with the potential to spread rapidly and widely, even with concerted global efforts, may affect the nervous system. We searched the scientific literature dating from 1934 to August 2020 to compile data on the cause, epidemiology, clinical presentation, neuroimaging features, and treatment of each of the diseases of epidemic or pandemic potential as viewed through a neurologist’s lens. We included articles with an abstract or full text in English in this topical and scoping review. Diseases with epidemic and pandemic potential can be spread directly from human to human, animal to human, via mosquitoes or other insects, or via environmental contamination. Manifestations include central neurologic syndromes (meningitis, encephalitis, intraparenchymal hemorrhage, seizures), peripheral and cranial nerve syndromes (sensory neuropathy, sensorineural hearing loss, ophthalmoplegia), post-infectious syndromes (acute infectious inflammatory polyneuropathy), and congenital syndromes (fetal microcephaly), among others. Some diseases have not been well characterized from a neurological standpoint, but all have at least scattered case reports of neurological features. Some of the diseases have curative treatments available although in other cases, supportive care remains the only management option. Regardless of the pathogen, prompt and aggressive measures to control the spread of these agents are the most important factors in lowering the overall morbidity and mortality they can cause.